Platforms like Cloudbyz, among others, are built around the principle that a case should be entered once and used everywhere: in coding, narratives, submissions and signal review. How far that shortens your timelines depends on configuration and on how your intake and review steps are set up.
Cloudbyz Safety & Pharmacovigilance runs natively on Salesforce and covers the case lifecycle from intake to regulatory reporting (Cloudbyz on Salesforce AppExchange). Its listed capabilities map to the features above:
|
Requirement |
How Cloudbyz handles it |
|---|---|
|
Intake and Day 0 |
Automated case intake into a structured case record |
|
Coding |
WHO Drug and MedDRA coding within the case |
|
Expectedness |
Dynamic auto-labelling against product labelling |
|
Narratives |
Template-based auto narratives with medical review |
|
Workflow and follow-up |
Configurable workflow automation with an audit trail |
|
Signals and aggregate reports |
Signal detection, aggregate reporting and risk management on the same data |
Because Cloudbyz EDC, CTMS and eTMF sit on the same platform, SAE data does not need to move between separate vendors' systems for reconciliation.
Cloudbyz is also developing AI VigiCheck, an agent designed to validate ICSRs against E2B(R3) and agency business rules before submission, check MedDRA codes against the current release, and score each case for completeness. As with every Cloudbyz AI agent, people stay in control: the agent flags and explains, and your safety team decides.
Book a demo and walk through intake, coding, narratives and E2B(R3) output using a scenario from your own studies. The session covers how the configuration would fit your SOPs, sponsors and regions.
Book a Cloudbyz Safety & PV demo or email info@cloudbyz.com.